BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 35662334)

  • 1. Association between polymorphisms of ABCB1 and prognosis in esophageal squamous cell carcinoma patients treated with taxane.
    Sun Z; Yang X; Du F; Shi Y; Sun J; Jia J; Liu C; Xiao Y; Yu J; Zhang X; Yang Y
    J Gene Med; 2022 Jul; 24(7):e3434. PubMed ID: 35662334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism of
    Yang Y; Jia J; Sun Z; Liu C; Li Z; Xiao Y; Yu J; Du F; Shi Y; Sun J; Shui J; Zhang X
    Future Oncol; 2021 Jun; 17(18):2351-2363. PubMed ID: 33709789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic aberrations of ABCB1 synergistically boost the acquisition of taxane resistance in esophageal squamous cancer cells.
    Sumarpo A; Ito K; Saiki Y; Ishizawa K; Wang R; Chen N; Sunamura M; Horii A
    Biochem Biophys Res Commun; 2020 Jun; 526(3):586-591. PubMed ID: 32247608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a genetic variant in ATP-binding cassette sub-family B member 1 gene with poor prognosis in patients with squamous cell carcinoma of the esophagus.
    Rastgar-Moghadam A; Mehramiz M; Shahidsales S; Entezari M; Hassanian SM; Talebian S; Nourbakhsh M; Ferns GA; Avan A
    IUBMB Life; 2019 Sep; 71(9):1252-1258. PubMed ID: 30865384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Two Polymorphisms, rs1045642 and rs1128503, in ABCB1 Following Taxane-based Chemotherapy: A Meta-Analysis.
    Chen Q; Lin W; Yang J; Lin M; Lin X; Weng Y; Chen Y
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):3-10. PubMed ID: 33507672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the ABCB1 polymorphisms on the response to Taxane-containing chemotherapy: a systematic review and meta-analysis.
    Jiang Q; Xu M; Liu Y; Chen Y; Feng J; Wang X; Liang S; Li D; Yang X
    Cancer Chemother Pharmacol; 2018 Feb; 81(2):315-323. PubMed ID: 29209772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCB1 Is Upregulated in Acquisition of Taxane Resistance: Lessons from Esophageal Squamous Cell Carcinoma Cell Lines.
    Wang R; Sumarpo A; Saiki Y; Chen N; Sunamura M; Horii A
    Tohoku J Exp Med; 2016 Dec; 240(4):295-301. PubMed ID: 27941276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy.
    Nomura H; Tsuji D; Demachi K; Mochizuki N; Matsuzawa H; Yano T; Daiko H; Fujii S; Kojima T; Itoh K; Kawasaki T
    Cancer Chemother Pharmacol; 2020 Aug; 86(2):315-324. PubMed ID: 32748110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intronic polymorphisms in genes LRFN2 (rs2494938) and DNAH11 (rs2285947) are prognostic indicators of esophageal squamous cell carcinoma.
    Wang J; Wang Q; Wei B; Zhou Y; Qian Z; Gao Y; Chen X
    BMC Med Genet; 2019 May; 20(1):72. PubMed ID: 31053115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different response rates to chemotherapy between Japanese and German esophageal squamous cell carcinoma: patients may be influenced by
    Narumiya K; Bollschweiler E; Hölscher AH; Yamamoto M; Drebber U; Alakus H; Metzger R; Warnecke-Eberz U
    Future Oncol; 2020 Sep; 16(27):2075-2087. PubMed ID: 32611208
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential Cumulative Risk of Genetic Polymorphisms in Familial and Nonfamilial Esophageal Squamous Cell Carcinoma.
    Suo C; Qing T; Liu Z; Yang X; Yuan Z; Yang YJ; Fan M; Zhang T; Lu M; Jin L; Chen X; Ye W
    Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2014-2021. PubMed ID: 31562207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor infiltrating lymphocyte signature is associated with single nucleotide polymorphisms and predicts survival in esophageal squamous cell carcinoma patients.
    Suo C; Chen H; Binczyk F; Zhao R; Fan J; Yang X; Yuan Z; Kreil D; Łabaj P; Zhang T; Lu M; Jin L; Polańska J; Chen X; Ye W
    Aging (Albany NY); 2021 Apr; 13(7):10369-10386. PubMed ID: 33819921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world outcomes with second-line therapy in advanced esophageal squamous cell carcinoma using SEER-Medicare data.
    Danese M; Gricar J; Abraham P
    Future Oncol; 2022 Mar; 18(8):927-936. PubMed ID: 35081734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIM-3 polymorphism is involved in the progression of esophageal squamous cell carcinoma by regulating gene expression.
    Cui SJ; Li Y; Zhou RM; Liu L; Cao SR; Huang X; Huo XR; Wang N
    Environ Mol Mutagen; 2021 Apr; 62(4):273-283. PubMed ID: 33723872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of ATM Polymorphisms With Survival in Advanced Esophageal Squamous Cell Carcinoma Patients Receiving Radiation Therapy.
    Du Z; Zhang W; Zhou Y; Yu D; Chen X; Chang J; Qiao Y; Zhang M; Huang Y; Wu C; Xiao Z; Tan W; Lin D
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):181-9. PubMed ID: 26094126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP1 Gene Polymorphisms and the Prognosis of Esophageal Cancer Patients from Cixian High-Incidence Region in Northern China.
    Zhou RM; Li Y; Wang N; Niu CX; Huang X; Cao SR; Huo XR
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2987-2992. PubMed ID: 33112558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma.
    Zhang W; Zhou Y; Li C; Xu S; Li M; Liu W; Ma Y; Wang H
    Anal Cell Pathol (Amst); 2020; 2020():2872479. PubMed ID: 33381388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib.
    Loscocco F; Visani G; Ruzzo A; Bagaloni I; Fuligni F; Galimberti S; Di Paolo A; Stagno F; Pregno P; Annunziata M; Gozzini A; Barulli S; Gabucci E; Magnani M; Isidori A
    Front Oncol; 2021; 11():672287. PubMed ID: 34055641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of ATP-binding cassette polymorphisms on neurological outcome after traumatic brain injury.
    Cousar JL; Conley YP; Willyerd FA; Sarnaik AA; Puccio AM; Empey PE; Kochanek PM; Bell MJ; Okonkwo DO; Clark RS
    Neurocrit Care; 2013 Oct; 19(2):192-8. PubMed ID: 23896815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane-based chemotherapy.
    Zhong J; Guo Z; Fan L; Zhao X; Zhao B; Cao Z; Cheng L; Shi Y; Li X; Zhang Y; An T; Wu M; Wang Y; Zhuo M; Li J; Yang X; Chen H; Jia B; Zhao J
    Thorac Cancer; 2019 Nov; 10(11):2088-2095. PubMed ID: 31571407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.